Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Try combinations like oats with nut butter, chia seeds, and banana for a mix of slow-digesting carbs, healthy fats, and a ...

Chilean foodtech firm NotCo says it expects to be profitable in Chile, Argentina, Colombia, and Peru in Q2, 2025.

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

We recently published a list of Was Jim Cramer Right About These 13 Stocks? In this article, we are going to take a look at ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Brady Henderson, 52, from Atlanta, Georgia, was desperate to lose weight and he managed to get a prescription for the appetite suppressant phentermine, sold under the brand name Adipex-P.

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

GLP-1 medications are changing the way we approach weight loss and chronic conditions. Dr. Nima Mowzoon of UBI Telehealth ...

When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off-label use by celebrities and social media influencers for cutting weight ...

Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.